Randomized, controlled trial of early intervention with pranlukast for prevention of bronchial asthma in infants with wheezy bronchitis and atopy
Not Applicable
- Conditions
- Infants between 1 and 3 years old, who have severe atopy defined by class 2 and more of Ig E to food and/or environment allergens and history of wheezy bronchitis twice.
- Registration Number
- JPRN-UMIN000000634
- Lead Sponsor
- Japanese Society of Pediatric Allergy and Clinical Immunology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Diagnosed as bronchial asthma and treated with anti-inflammation drugs. 2. Treated with Pranlukast continuously in the past. 3. Treated with anti-histaminics (including anti-allergic drugs) for more than 6 months in the past.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method occurence of intermittent asthma attack or shift to persistent ashtma
- Secondary Outcome Measures
Name Time Method